Last Updated: June 30, 2026

Claims for Patent: 10,065,991

✉ Email this page to a colleague

Summary for Patent: 10,065,991

Title:	Peptides that can be used in coating agents, adhesion promoters or adhesives for oxidic surfaces
Abstract:	The present invention relates to peptides, in particular dodecapeptide-containing coating agents, adhesion promoters or adhesives for oxidic surfaces, a multilayer composite or a coated substrate, containing compounds which are formed entirely or in part of dodecapeptides as adhesion promoters between at least two adjacent layers of the composite or between the coating and the substrate, and to dodecapeptides that can be used as coating agents, adhesion promoters or adhesives for oxidic surfaces.
Inventor(s):	Andreas Taden, Birgit VEITH, Roland Breves, Irmgard Schmidt, Thomas Weber, Joachim Jose, Claudia REICHENEDER
Assignee:	Henkel AG and Co KGaA
Application Number:	US14/705,682

Details for Patent 10,065,991

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Takeda Pharmaceuticals U.s.a., Inc.	ADYNOVATE	antihemophilic factor (recombinant), pegylated	For Injection	125566	November 13, 2015	⤷ Start Trial	2035-05-06
Takeda Pharmaceuticals U.s.a., Inc.	ADYNOVATE	antihemophilic factor (recombinant), pegylated	For Injection	125566	October 25, 2016	⤷ Start Trial	2035-05-06
Takeda Pharmaceuticals U.s.a., Inc.	ADYNOVATE	antihemophilic factor (recombinant), pegylated	For Injection	125566	March 13, 2017	⤷ Start Trial	2035-05-06
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,065,991

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Brazil	112015009995	⤷ Start Trial
China	104769437	⤷ Start Trial
Germany	102012110664	⤷ Start Trial
European Patent Office	2917740	⤷ Start Trial
European Patent Office	3118627	⤷ Start Trial
Spain	2621261	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.